$GRPS
Trans American Aquaculture, Inc Stock $grps

$grps Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000168316824004606 Filed on July 02, 2024

Income Statement

Concept	2024 Q2	2023
Revenue
YoY Change
Cost Of Revenue	$1.771K	$661.6K
YoY Change		130.41%
Gross Profit	$3.248K	-$560.0K
YoY Change		135.17%
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$69.91K
YoY Change		-18.66%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense		$490.1K
YoY Change		0.95%
% of Operating Profit
Other Income/Expense, Net	-$206.6K	-$497.1K
YoY Change	71.29%	-2.36%
Pretax Income	-$330.3K	-$1.922M
YoY Change	11.57%	114.53%
Income Tax	$0.00	-$26.94K
% Of Pretax Income
Net Earnings	-$330.3K	-$1.895M
YoY Change	11.57%	105.35%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	1.417B shares	1.452B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$0.00	$6.600K
Short-Term Investments
Other Short-Term Assets	$904.00	$0.00
YoY Change
Inventory	$370.7K	$247.4K
Prepaid Expenses
Receivables
Other Receivables	$30.53K	$0.00
Total Short-Term Assets	$402.1K	$254.0K
YoY Change		22.35%
LONG-TERM ASSETS
Property, Plant & Equipment		$7.408M
YoY Change		-0.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$7.385M	$7.408M
YoY Change		-0.73%
TOTAL ASSETS
Total Short-Term Assets	$402.1K	$254.0K
Total Long-Term Assets	$7.385M	$7.408M
Total Assets	$7.787M	$7.662M
YoY Change		-0.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$379.3K	$403.7K
YoY Change		80.66%
Accrued Expenses		$789.3K
YoY Change		76.62%
Deferred Revenue
YoY Change
Short-Term Debt	$1.047M	$525.6K
YoY Change		60.88%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.578M	$3.732M
YoY Change		38.34%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$4.222M	$4.332M
YoY Change		-5.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.578M	$3.732M
Total Long-Term Liabilities	$4.222M	$4.332M
Total Liabilities	$8.800M	$8.065M
YoY Change		10.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.556M	-$2.867M
YoY Change		210.64%
Common Stock	$135.1K	$100.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.012M	-$402.7K
YoY Change
Total Liabilities & Shareholders Equity	$7.787M	$7.662M
YoY Change		-0.11%

Cashflow Statement

Concept	2024 Q2	2023
OPERATING ACTIVITIES
Net Income	-$330.3K	-$1.895M
YoY Change	11.57%	105.35%
Depreciation, Depletion And Amortization		$69.91K
YoY Change		-18.66%
Cash From Operating Activities		-$1.108M
YoY Change		119.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$15.13K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$1.130M
YoY Change		121.54%
NET CHANGE
Cash From Operating Activities		-$1.108M
Cash From Investing Activities		-$15.13K
Cash From Financing Activities		$1.130M
Net Change In Cash		$6.600K
YoY Change
FREE CASH FLOW
Cash From Operating Activities		-$1.108M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001990446
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Security12g Title Security12gTitle	Common Stock, par value $0.000001 per share
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	5221790	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1416654274	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	384
CY2023	dei	Auditor Name AuditorName	Burton, McCumber & LOngoria, LLP
CY2023	dei	Auditor Location AuditorLocation	Brownsville, Texas
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6600	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	0	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	46038	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	247393	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	161560	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	253993	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	207598	usd
CY2023Q4	GRPS	Land Property Plant And Equipment Gross LandPropertyPlantAndEquipmentGross	7935824	usd
CY2022Q4	GRPS	Land Property Plant And Equipment Gross LandPropertyPlantAndEquipmentGross	7920692	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	527827	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	457920	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7407997	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7462772	usd
CY2023Q4	us-gaap	Assets Assets	7661990	usd
CY2022Q4	us-gaap	Assets Assets	7670370	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	0	usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	288	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	403731	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	223476	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	789265	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	446870	usd
CY2023Q4	GRPS	Other Accrued Expenses Current OtherAccruedExpensesCurrent	345825	usd
CY2022Q4	GRPS	Other Accrued Expenses Current OtherAccruedExpensesCurrent	138532	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	46038	usd
CY2023Q4	GRPS	Related Parties Notes RelatedPartiesNotes	1667985	usd
CY2022Q4	GRPS	Related Parties Notes RelatedPartiesNotes	1516025	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	525609	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	326716	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3732416	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2697945	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4332293	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4581215	usd
CY2023Q4	GRPS	Long Term Deferred Tax Liability Net LongTermDeferredTaxLiabilityNet	0	usd
CY2022Q4	GRPS	Long Term Deferred Tax Liability Net LongTermDeferredTaxLiabilityNet	26937	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4332293	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4608152	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1452655528	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1452655528	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1432655528	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1432655528	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	20	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	99980	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	usd
CY2023Q4	GRPS	Additional Paid In Capital Preferred Stock Series C AdditionalPaidInCapitalPreferredStockSeriesC	1287091	usd
CY2022Q4	GRPS	Additional Paid In Capital Preferred Stock Series C AdditionalPaidInCapitalPreferredStockSeriesC	1287091	usd
CY2023Q4	GRPS	Additional Paid In Capital Preferred Stock Series D AdditionalPaidInCapitalPreferredStockSeriesD	1076863	usd
CY2022Q4	GRPS	Additional Paid In Capital Preferred Stock Series D AdditionalPaidInCapitalPreferredStockSeriesD	0	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2866673	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-922817	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-402719	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	364274	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7661990	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7670370	usd
CY2023	GRPS	Sales And Service SalesAndService	101574	usd
CY2022	GRPS	Sales And Service SalesAndService	49001	usd
CY2021	GRPS	Sales And Service SalesAndService	316112	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	661591	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	287132	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	973418	usd
CY2023	us-gaap	Gross Profit GrossProfit	-560018	usd
CY2022	us-gaap	Gross Profit GrossProfit	-238131	usd
CY2021	us-gaap	Gross Profit GrossProfit	-657306	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	864768	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	148609	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	232425	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1750	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1746	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	32447	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	8841	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	25440	usd
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	-0	usd
CY2023	us-gaap	Interest Expense InterestExpense	490053	usd
CY2022	us-gaap	Interest Expense InterestExpense	485446	usd
CY2021	us-gaap	Interest Expense InterestExpense	544544	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-497144	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-509140	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-512097	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1921930	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-895880	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1401828	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-26937	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26937	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1894993	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-922817	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1401828	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.001271
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.001271
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.000713
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.000713
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1452215968	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1294840264	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	544830	usd
CY2021	GRPS	Stock Issued During Period Value Member Contributions StockIssuedDuringPeriodValueMemberContributions	1633953	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1401828	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	776955	usd
CY2022	GRPS	Stock Issued During Period Value Member Contributions StockIssuedDuringPeriodValueMemberContributions	510136	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-922817	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	364274	usd
CY2023	GRPS	Stock Issued During Period Value Issuance Of Common Value StockIssuedDuringPeriodValueIssuanceOfCommonValue	100000	usd
CY2023	GRPS	Stock Issued During Period Value Issuance Of Preferred Value StockIssuedDuringPeriodValueIssuanceOfPreferredValue	1028000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1894993	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-402719	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-922817	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1401828	usd
CY2023	us-gaap	Depreciation Depreciation	69907	usd
CY2022	us-gaap	Depreciation Depreciation	85949	usd
CY2021	us-gaap	Depreciation Depreciation	98889	usd
CY2023	GRPS	Common Stock Issued For Professional Services CommonStockIssuedForProfessionalServices	100000	usd
CY2022	GRPS	Common Stock Issued For Professional Services CommonStockIssuedForProfessionalServices	0	usd
CY2021	GRPS	Common Stock Issued For Professional Services CommonStockIssuedForProfessionalServices	0	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-46038	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	46038	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-0	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	85833	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	112924	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	48636	usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	26937	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-26937	usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-0	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-0	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-0	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-17024	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	387549	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	33685	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	70060	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-46038	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	46038	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	342395	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	383267	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1107912	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-505903	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1264491	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	15132	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	-0	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4159	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15132	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4159	usd
CY2023	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-288	usd
CY2022	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-3876	usd
CY2021	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-2742	usd
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	288	usd
CY2021	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	3876	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	255227	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	112975	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	816560	usd
CY2023	GRPS	Payments On Shareholder Notes Payable PaymentsOnShareholderNotesPayable	103266	usd
CY2022	GRPS	Payments On Shareholder Notes Payable PaymentsOnShareholderNotesPayable	16469	usd
CY2021	GRPS	Payments On Shareholder Notes Payable PaymentsOnShareholderNotesPayable	-0	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	50029	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	97151	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	144753	usd
CY2023	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0	usd
CY2022	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	510136	usd
CY2021	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	595709	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1028000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1129644	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	509903	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1268650	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6600	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	0	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6600	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	22518	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	85463	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	GRPS	Preferred Series D Stock Dividends PreferredSeriesDStockDividends	0	usd
CY2021	GRPS	Preferred Series D Stock Dividends PreferredSeriesDStockDividends	0	usd
CY2023	GRPS	Common Stock Issued For Services Rendered CommonStockIssuedForServicesRendered	100000	usd
CY2022	GRPS	Common Stock Issued For Services Rendered CommonStockIssuedForServicesRendered	0	usd
CY2021	GRPS	Common Stock Issued For Services Rendered CommonStockIssuedForServicesRendered	0	usd
CY2023	GRPS	Capitalization Of Related Party Member Notes To Members Capital CapitalizationOfRelatedPartyMemberNotesToMembersCapital	0	usd
CY2022	GRPS	Capitalization Of Related Party Member Notes To Members Capital CapitalizationOfRelatedPartyMemberNotesToMembersCapital	0	usd
CY2021	GRPS	Capitalization Of Related Party Member Notes To Members Capital CapitalizationOfRelatedPartyMemberNotesToMembersCapital	1038243	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2020	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	445500	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	155200	usd
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	33180	usd
CY2023Q3	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	58256	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_z1ddFyVqk6de" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #1F1F1F"><span style="text-decoration: underline"><span id="xdx_86B_zOiwIMS1bnpi">Use of Estimates</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zrbINMWvn7u7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #1F1F1F"><span style="text-decoration: underline"><span id="xdx_86E_zNTWx05mPp2k">Concentrations of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #212121">The Company's financial instruments that are exposed to credit risk consist primarily of temporary cash investments and accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #1F1F1F"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.05pt; color: #1C1C1C">The Company maintains its cash balances at a large financial institution. At times such balances may exceed federally insured limits. The Company has not experienced any losses in an account. The Company believes it is not exposed to any significant credit risk on cash and had no balances in excess of the $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zWo5ojRabc46" title="FDIC limit">250,000</span> FDIC limit for the year ended December 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #1C1C1C"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #1F1F1F">For the years ended December 31, 2023, 2022 and 2021, one customer accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zPQlWC5BuONd" title="Concentration risk, percentage">100</span>%, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zCjJgwi61Jlf" title="Concentration risk, percentage">100</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zTT7LXVmfALa" title="Concentration risk, percentage">91</span>% of total revenues earned, respectively. At December 31, 2022 and 2021, there were no accounts receivable from any customers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #1F1F1F"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #1F1F1F">The Company’s sole source of expected future revenue consists of the sale of a single live product which requires substantial care. Production risks such as weather, disease and other factors could affect the Company’s ability to realize revenue from its inventory stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #1F1F1F"> </p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	191031	usd
CY2022Q4	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	0	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	247393	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	161560	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	579916	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1809581	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1794449	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	527827	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	457920	usd
CY2023Q4	GRPS	Property Plant And Equipment Excluding Land Net PropertyPlantAndEquipmentExcludingLandNet	1281754	usd
CY2022Q4	GRPS	Property Plant And Equipment Excluding Land Net PropertyPlantAndEquipmentExcludingLandNet	1336529	usd
CY2023Q4	us-gaap	Land Land	6126243	usd
CY2022Q4	us-gaap	Land Land	6126243	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7407997	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7462772	usd
CY2022	us-gaap	Depreciation Depreciation	85949	usd
CY2021	us-gaap	Depreciation Depreciation	98889	usd
CY2023	us-gaap	Depreciation Nonproduction DepreciationNonproduction	68357	usd
CY2022	us-gaap	Depreciation Nonproduction DepreciationNonproduction	84238	usd
CY2021	us-gaap	Depreciation Nonproduction DepreciationNonproduction	84238	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	4857902	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	525609	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	4332293	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	525609	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	222000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	235627	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	250092	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	265445	usd
CY2023Q4	GRPS	Long Term Debt Maturities Repayments Of Principal Therafter LongTermDebtMaturitiesRepaymentsOfPrincipalTherafter	3359129	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	4857902	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	394890	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	403605	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	59323	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	8715	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	86260	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	394890	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	26937	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	394890	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	26937	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-26937	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26937	usd

Files In Submission

Name	View Source	Status
0001683168-24-004606-index-headers.html	Edgar Link	pending
0001683168-24-004606-index.html	Edgar Link	pending
0001683168-24-004606.txt	Edgar Link	pending
0001683168-24-004606-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
grps-20231231.xsd	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
grps-20231231_cal.xml	Edgar Link	unprocessable
grps-20231231_def.xml	Edgar Link	unprocessable
grps-20231231_lab.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
transaqua_ex3101.htm	Edgar Link	pending
transaqua_ex3102.htm	Edgar Link	pending
transaqua_ex3201.htm	Edgar Link	pending
transaqua_ex3202.htm	Edgar Link	pending
transaqua_i10k-123123.htm	Edgar Link	pending
transaqua_i10k-123123_htm.xml	Edgar Link	completed
grps-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GRPS
Trans American Aquaculture, Inc Stock $grps

2024 Q2 Form 10-K Financial Statement

#000168316824004606 Filed on July 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRPS Trans American Aquaculture, Inc Stock $grps

2024 Q2 Form 10-K Financial Statement

#000168316824004606 Filed on July 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRPS
Trans American Aquaculture, Inc Stock $grps